Immuno Diagnostics

What Immuno Diagnostics does

Immuno Diagnostics Pvt. Ltd. is a Delhi-NCR based immunoassay diagnostics laboratory founded in 1999 by Dr. Ajay Kumar Ph.D., who brought prior expertise from faculty roles at Bhabha Atomic Research Centre (BARC) and Thyrocare Mumbai. The company operates a single central state-of-the-art laboratory in Sarita Vihar, South Delhi, with a stated capacity of 10,000 tests per day, supported by a network of 13+ collection centers across Delhi-NCR localities including Mukherjee Nagar, Malviya Nagar, Laxmi Nagar, Karol Bagh, Janakpuri, Saket, Noida, and Gurugram. Its core technology is immunoassay-based pathology testing — detecting proteins, hormones, and biomarkers in blood samples — covering panels for thyroid, joints, fever, diabetes, heart, kidney, liver, pregnancy, and vitamins, alongside a bundled Full Body Test. The lab holds NABL accreditation (2022-2024), ISO 13485 certification (MC-6428, valid 18.03.2022-17.03.2025), and ICMR certification, and is recognized by NABL as North India's largest laboratory.

The company serves three primary customer segments: individual patients seeking preventive or diagnostic testing directly (B2C), referring physicians and partner hospitals/laboratories (B2B referral), and corporate clients purchasing wellness packages for employee health programs. Revenue is generated on a unit-pricing, pay-as-you-go basis across individual tests, with quote-based pricing undisclosed publicly. A corporate wellness line offers pre-employment checkups, annual health checkups, onsite camps, and wellness workshops. The 13+ physical collection centers function as the main distribution channel, complemented by a website with online report access and inquiry-based direct sales for both retail and corporate inquiries. Customer throughput is reported at over 12 lakh+ tests annually.

The business is privately held with no disclosed funding, M&A activity, or leadership transitions, and is structured as an Indian private limited company. Strategic positioning has been anchored on compliance stacking (NABL + ISO + ICMR), founder-led specialty expertise in immunoassays, regional scale in Northern India, and same-day reporting rather than on technology-led differentiation. The primary forward-looking risks are the absence of digital/AI-enabled reporting capabilities relative to digital-native diagnostic competitors, geographic concentration in a single region (Delhi-NCR), and limited disclosed financial transparency.

Name

Immuno Diagnostics

Legal name

Immuno Diagnostics Pvt. Ltd.

Website

https://immunodiag.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Immuno Diagnostics Pvt. Ltd. is a Delhi-NCR based NABL-, ISO-, and ICMR-certified immunoassay pathology laboratory founded in 1999, operating a 10,000-tests-per-day central lab and 13+ collection centers serving individuals, referring physicians, hospitals, and corporate wellness clients across Northern India.

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

akta.pro secondary industries

Clinical Chemistry & Immunoassay Systems (HLAHAAAA), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Diagnostic laboratory services
• Pathology testing services
• Immunoassay diagnostics
• Blood test services
• Corporate health checkups

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices10 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Diagnostic Testing Services: Revenue generated from individual pathology tests including CBC, Kidney Function Test, Lipid Profile, Liver Function Test, Thyroid Function Test, and various other diagnostic tests. Customers pay for individual tests as needed.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Immuno Diagnostics operates a NABL/ICMR/ISO-accredited pathology laboratory offering immunoassay-based diagnostic tests across categories such as thyroid, kidney, liver, heart, diabetes, fever, vitamins, pregnancy, joints, and full-body panels. Services are delivered to individual patients, doctors, hospitals, and corporate clients through 13+ collection centers across Delhi-NCR and a central laboratory in South Delhi, with same-day reporting and online report access.

Product overview

Immuno Diagnostics offers a comprehensive pathology laboratory service portfolio centered around immunoassay diagnostics. The company operates as a modern pathology lab established in 1999, providing over 10,000 diagnostic tests per day across multiple categories. The core product offerings include individual diagnostic tests (CBC, KFT, Lipid Profile, LFT, Thyroid Function) organized by health categories (Heart, Kidney, Diabetes, Fever, Vitamins, Liver, Pregnancy, Joints), as well as bundled wellness packages. The company also provides B2B Corporate Wellness services offering pre-employment checkups, annual health checkups, wellness workshops, and onsite camps. All services are delivered through their NABL-accredited laboratory in Okhla, New Delhi, with same-day reporting capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• CBC Test
• Kidney Function Test (KFT)
• Lipid Profile
• Liver Function Test (LFT)
• Thyroid Function Test
• Heart Test Panel
• Diabetes Test Panel
• Fever Test Panel
• Vitamin Test Panel
• Liver Test Panel
• Pregnancy Test Panel
• Joints Test Panel
• Full Body Test
• Corporate Wellness Program

Quantifiable outcome

• 100% accuracy in test results
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Healthians: Direct-to-consumer diagnostics startup focused on at-home sample collection with a strong digital/tech layer. Competes with Immuno Diagnostics for the same Delhi-NCR consumer in routine pathology, but differentiates via home-collection logistics and an app-based booking experience.
• Tata 1mg Labs: Digital diagnostics and pharmacy platform (backed by Tata Digital) offering lab tests with home sample collection across major Indian cities including Delhi-NCR. Comparable on routine immunoassay and biochemistry tests, with a stronger technology and consumer-brand layer.

Broad incumbents

• Apollo Diagnostics: Diagnostic arm of Apollo Hospitals, one of India's largest hospital groups. Comparable routine and specialty pathology offerings, with the advantage of hospital-network referrals. Operates nationally including Delhi-NCR.
• Max Lab: Diagnostic arm of Max Healthcare, one of the largest hospital networks in North India. Directly competes for the same Delhi-NCR patient and hospital-referral base as Immuno Diagnostics, with the added advantage of Max Hospital physician referrals.

Direct peers

• SRL Diagnostics: One of India's largest pathology networks, owned by Agilus Diagnostics (subsidiary of Fortis Healthcare). Comparable across routine and specialty immunoassays, hospital B2B partnerships, and collection-center distribution. Operates nationwide including Delhi-NCR.
• Thyrocare Technologies: National preventive diagnostics chain specializing in immunoassays and thyroid panels, founded by Dr. A. Velumani. Highly comparable core technology (immunoassay) and B2B partner-lab business model. Notably, Immuno Diagnostics' founder Dr. Ajay Kumar previously taught at Thyrocare, illustrating the close technical lineage.
• Metropolis Healthcare: Pan-India diagnostic chain with strong presence in western and southern India, expanding into North India. Comparable across immunoassay, biochemistry, and specialty panels, with similar B2B hospital referral and B2C walk-in channels.
• Dr. Lal PathLabs: India's largest diagnostic chain by revenue and network. Directly comparable pathology laboratory offering, with the same immunoassay, biochemistry, and routine test categories. Both serve physicians, hospitals, and walk-in patients across India, though Dr. Lal PathLabs has a national footprint versus Immuno Diagnostics' Delhi-NCR focus.

Regional players

• Suburban Diagnostics: Established pathology chain with strong western India (Maharashtra) presence. Comparable across routine and specialty immunoassay panels and the B2B referral model, though geographic overlap with Immuno Diagnostics is limited.
• Vijaya Diagnostic Centre: Hyderabad-headquartered diagnostic chain with strong South India presence, comparable in offering routine and specialty pathology tests including immunoassays. Limited direct overlap with Immuno Diagnostics in Delhi-NCR but relevant as a similarly scaled regional competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/immuno-diagnostics-pvt-ltd

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Immuno Diagnostics